Log in
LON:AZN

AstraZeneca PLC (AZN.L) Share Forecast, Price & News

GBX 7,943
-12.00 (-0.15 %)
(As of 10/23/2020 04:37 PM ET)
Add
Compare
Today's Range
7,895
Now: GBX 7,943
8,031.42
50-Day Range
7,920
MA: GBX 8,393.32
8,812
52-Week Range
5,871
Now: GBX 7,943
£101.20
Volume1.01 million shs
Average Volume2.00 million shs
Market Capitalization£104.24 billion
P/E Ratio48.52
Dividend Yield2.73%
BetaN/A
AstraZeneca PLC discovers, develops, and commercializes prescription medicines in the areas of oncology, cardiovascular, renal and metabolism, respiratory, autoimmunity, infection, neuroscience, and gastroenterology worldwide. Its marketed products include Arimidex, Casodex/Cosudex, Calquence, Faslodex, Imfinzi, Iressa, Lynparza, Nolvadex, Tagrisso, and Zoladex for oncology diseases; Atacand/Atacand HCT/Atacand Plus, Brilinta/Brilique, Crestor, Plendil, Seloken/Toprol-XL, Tenormin, and Zestril for cardiovascular diseases; and Bydureon, Byetta, Farxiga/Forxiga, Kombiglyze XR/Komboglyze, Onglyza, Qtern, Symlin, Xigduo/Xigduo XR for metabolic diseases. The company's marketed products also comprise Accolate, Bevespi Aerosphere, Bricanyl Respules, Bricanyl Turbuhaler, Daliresp/Daxas, Duaklir Genuair, Tudorza/Eklira, Fasenra, Oxis Turbuhaler, Pulmicort Turbuhaler/Pulmicort Flexhaler, Pulmicort Respules, Symbicort pMDI, and Symbicort Turbuhaler for respiratory diseases; Fluenz Tetra/FluMist Quadrivalen and Synagis for infection diseases; Movantik/Moventig, Seroquel IR/Seroquel XR, and Vimovo for neuroscience diseases; and Losec/Prilosec and Nexium for gastrointestinal diseases. The company serves primary care and specialty care physicians through distributors and local representative offices. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was founded in 1992 and is headquartered in Cambridge, the United Kingdom.
Read More
AstraZeneca PLC (AZN.L) logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.2Community Rank: 2.4Dividend Strength: 0.8Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.08 out of 5 stars

Industry, Sector and Symbol

Industry Drug Manufacturers - Major
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+44-20-73045000
Employees70,600

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£25.70 billion
Cash FlowGBX 465.40 per share
Book ValueGBX 932.70 per share

Profitability

Miscellaneous

Outstanding Shares1,312,300,032
Market Cap£104.24 billion
Next Earnings Date11/5/2020 (Estimated)
OptionableOptionable
GBX 7,943
-12.00 (-0.15 %)
(As of 10/23/2020 04:37 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive AZN News and Ratings via Email

Sign-up to receive the latest news and ratings for AZN and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











AstraZeneca PLC (AZN.L) (LON:AZN) Frequently Asked Questions

How has AstraZeneca PLC (AZN.L)'s stock been impacted by COVID-19 (Coronavirus)?

AstraZeneca PLC (AZN.L)'s stock was trading at GBX 6,955 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, AZN stock has increased by 14.2% and is now trading at GBX 7,943.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of AstraZeneca PLC (AZN.L)?

20 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AstraZeneca PLC (AZN.L) in the last year. There are currently 6 sell ratings, 2 hold ratings and 12 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for AstraZeneca PLC (AZN.L)
.

When is AstraZeneca PLC (AZN.L)'s next earnings date?

AstraZeneca PLC (AZN.L) is scheduled to release its next quarterly earnings announcement on Thursday, November 5th 2020.
View our earnings forecast for AstraZeneca PLC (AZN.L)
.

How often does AstraZeneca PLC (AZN.L) pay dividends? What is the dividend yield for AstraZeneca PLC (AZN.L)?

AstraZeneca PLC (AZN.L) declared a dividend on Thursday, July 30th. Stockholders of record on Thursday, August 13th will be given a dividend of GBX 69.60 per share on Monday, September 14th. This represents a yield of 0.8%. The ex-dividend date of this dividend is Thursday, August 13th. The official announcement can be seen at this link.
View AstraZeneca PLC (AZN.L)'s dividend history
.

What price target have analysts set for AZN?

20 analysts have issued 12-month price targets for AstraZeneca PLC (AZN.L)'s shares. Their forecasts range from GBX 6,300 to £105. On average, they expect AstraZeneca PLC (AZN.L)'s stock price to reach GBX 8,421.18 in the next year. This suggests a possible upside of 6.0% from the stock's current price.
View analysts' price targets for AstraZeneca PLC (AZN.L)
.

Has AstraZeneca PLC (AZN.L) been receiving favorable news coverage?

Media coverage about AZN stock has been trending somewhat positive this week, InfoTrie Sentiment Analysis reports. InfoTrie ranks the sentiment of media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. AstraZeneca PLC (AZN.L) earned a news impact score of 0.7 on InfoTrie's scale. They also assigned media headlines about the biopharmaceutical company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the immediate future.
View the latest news about AstraZeneca PLC (AZN.L)
.

Who are some of AstraZeneca PLC (AZN.L)'s key competitors?

What other stocks do shareholders of AstraZeneca PLC (AZN.L) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AstraZeneca PLC (AZN.L) investors own include GlaxoSmithKline plc (GSK.L) (GSK), NVIDIA (NVDA), Gilead Sciences (GILD), Intel (INTC), Vodafone Group Plc (VOD.L) (VOD), Advanced Micro Devices (AMD), Alibaba Group (BABA), Pfizer (PFE), QUALCOMM (QCOM) and The Hain Celestial Group (HAIN).

Who are AstraZeneca PLC (AZN.L)'s key executives?

AstraZeneca PLC (AZN.L)'s management team includes the following people:
  • Mr. Pascal Soriot D.V.M., M.B.A., CEO & Exec. Director (Age 61, Pay $3.84M)
  • Mr. Marc Dunoyer, CFO & Exec. Director (Age 68, Pay $2.02M)
  • Ms. Pam P. Cheng, Exec. Vice-Pres of Operations & Information Technology (Age 49)
  • Prof. Ralph Knöll, Chief Scientist
  • Thomas Kudsk Larsen, Head of Investor Relations
  • Mr. Jefrey Pott, Gen. Counsel
  • Ms. Katarina Ageborg, Exec. VP of Sustainability & Chief Compliance Officer
  • Ms. Fiona Cicconi, Exec. VP of HR
  • Dr. Menelas Pangalos, Exec. Vice-Pres of BioPharmaceuticals R&D
  • Dr. Ruud Dobber, Exec. Vice-Pres of BioPharmaceuticals Bus. Unit

What is AstraZeneca PLC (AZN.L)'s stock symbol?

AstraZeneca PLC (AZN.L) trades on the London Stock Exchange (LON) under the ticker symbol "AZN."

How do I buy shares of AstraZeneca PLC (AZN.L)?

Shares of AZN and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is AstraZeneca PLC (AZN.L)'s stock price today?

One share of AZN stock can currently be purchased for approximately GBX 7,943.

How big of a company is AstraZeneca PLC (AZN.L)?

AstraZeneca PLC (AZN.L) has a market capitalization of £104.24 billion and generates £25.70 billion in revenue each year. AstraZeneca PLC (AZN.L) employs 70,600 workers across the globe.

What is AstraZeneca PLC (AZN.L)'s official website?

The official website for AstraZeneca PLC (AZN.L) is www.astrazeneca.com.

How can I contact AstraZeneca PLC (AZN.L)?

AstraZeneca PLC (AZN.L)'s mailing address is 1 Francis Crick Avenue Cambridge Biomedical Campus, CAMBRIDGE, CB2 0AA, United Kingdom. The biopharmaceutical company can be reached via phone at +44-20-73045000.

This page was last updated on 10/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.